作者: J.C. Lindsey , S.K. Shah , G.K. Siberry , P. Jean-Philippe , M.J. Levin
DOI: 10.1111/DEWB.12028
关键词:
摘要: The Declaration of Helsinki and the Council International Organization Medical Sciences provide guidance on standards care prevention in clinical trials. In current increasingly challenging research environment, ethical status a trial design depends not only protection participants, but also social value, feasibility, scientific validity. Using example study assessing efficacy vaccine to prevent human papilloma virus HIV-1 infected adolescent girls low resource countries without access vaccine, we compare several designs which rank lower some criteria higher others, giving rise difficult trade-offs. This case demonstrates need for developing more nuanced documents help researchers balance these often conflicting criteria.